You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API delafloxacin meglumine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing delafloxacin meglumine

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Melinta Therapeutics LLC	BAXDELA	delafloxacin meglumine	70842-101	ANHYDROUS CITRIC ACID	2031-06-19
Melinta Therapeutics LLC	BAXDELA	delafloxacin meglumine	70842-101	CELLULOSE, MICROCRYSTALLINE	2031-06-19
Melinta Therapeutics LLC	BAXDELA	delafloxacin meglumine	70842-101	CROSPOVIDONE	2031-06-19
Melinta Therapeutics LLC	BAXDELA	delafloxacin meglumine	70842-101	MAGNESIUM STEARATE	2031-06-19
Melinta Therapeutics LLC	BAXDELA	delafloxacin meglumine	70842-101	POVIDONE K30	2031-06-19
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for delafloxacin meglumine

Excipient focus: ANHYDROUS CITRIC ACID

delafloxacin meglumine drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

delafloxacin meglumine drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

delafloxacin meglumine drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

delafloxacin meglumine drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

delafloxacin meglumine drug variants containing POVIDONE K30

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing POVIDONE K30

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM BICARBONATE

delafloxacin meglumine drug variants containing SODIUM BICARBONATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing SODIUM BICARBONATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

delafloxacin meglumine drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

delafloxacin meglumine drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Melinta Therapeutics LLC	delafloxacin meglumine	70842-101
>Company	>Ingredient	>NDC

delafloxacin meglumine drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.